Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-22 @ 4:15 PM
Study NCT ID:
NCT01633060
Status:
TERMINATED
Last Update Posted:
2019-01-30
First Post:
2012-06-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-29
First Submit QC Date:
None
Study First Post Date:
2012-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-20
Results First Submit QC Date:
None
Results First Post Date:
2019-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-09
Last Update Post Date:
2019-01-30
Last Update Post Date Type:
ACTUAL